Advertisement Search POZ Search 148 results found Advanced Search #sofosbuvir A collection of content all about sofosbuvir. Hepatitis C Drugs Show Promise Against New Coronavirus Jul 12, 2020: Sofosbuvir and daclatasvir were linked to faster recovery and improved survival in studies in Iran. Reyataz HIV Medication May 11, 2020: Reyataz is a protease inhibitor HIV Medication. Reyataz was approved by the FDA in 2003. Prezista HIV Medication May 11, 2020: Prezista is a protease inhibitor HIV Medication. Prezista was approved by the FDA in October 2008. Do People With HIV Fare Worse After Being Cured of Hepatitis C? Sep 3, 2020: Rates of liver complications were similar, but HIV-positive people had more non-liver cancers and non-liver-related deaths. Shortened Epclusa Regimen Not as Effective for Recent Hep C Infection Mar 16, 2020: Six weeks, compared with the standard 12 weeks, was associated with an unacceptably high rate of viral relapse. Hepatitis C Treatments Are Safe and Effective for Seniors Oct 28, 2019: The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable. FDA OKs Major New Hepatitis C Drug, Sovaldi (Sofosbuvir) Dec 6, 2013: The FDA has approved Sovaldi (sofosbuvir), a once-daily oral nucleotide analog polymerase inhibitor to treat people with hepatitis C. Sofosbuvir, Daclatasvir Combo Cures 100% in Hep C Trial Apr 29, 2013: Sofosbuvir and daclatasvir, taken with or without ribavirin, cured 100 percent of previously treated participants of hepatitis C virus in... Sofosbuvir and Ribavirin Fare Well Among HIV-HCV Coinfected Nov 4, 2013: Sofosbuvir and ribavirin cured between 67 and 88 percent of those coinfected with HIV and genotypes 1, 2 or 3 of hepatitis C virus. Hepatitis C Can Be Cured With Minimal Monitoring Feb 12, 2021: Despite limited testing and clinical visits, 95% of the study population was able to achieve a sustained virological response. Young People With Lifelong HIV and HCV Respond Well to Hep C Treatment Jul 27, 2019: Cure rates are high, but some young people already have advanced liver damage by the time they’re treated. Pharmacist-Driven Hep C Treatment Sees Good Cure Rates Jul 22, 2019: Pharmacists oversaw the delivery of hepatitis C treatment in a recent study. High Hep C Cure Rate for Daclatasvir and Sovaldi in Those With HIV Apr 27, 2015: Daclatasvir and sofosbuvir cured 97 percent of hepatitis C among those with genotypes 1 through 4 of the virus who are coinfected with HIV. Sofosbuvir (GS-7977) Shows Promise in HIV/Hep C-Coinfected People Sep 17, 2012: Gilead Sciences’ experimental NS5B polymerase inhibitor sofosbuvir (GS-7977) rapidly reduced hepatitis C virus (HCV) levels in people coinfect... Real-World Hepatitis C Cure Rates Are Excellent in Europeans With HIV Apr 24, 2018: In a recent study of more than 600 HIV-positive adults, 93 percent were cured of hep C. Providing Naloxone to People Who Inject Drugs During Hep C Care Drives Up Use Oct 15, 2019: The drug can quickly reverse opioid-driven overdoses. 100% Cure Rate for Hep C With Sofosbuvir, Ledipasvir Combo Therapy Mar 13, 2013: An all-oral combination therapy of sofosbuvir, ledipasvir and ribavirin boasts a 100 percent cure rate among people with hepatitis C virus. Simeprevir and Sofosbuvir Achieve High Cure Rates in Hep C Null-Responders Mar 11, 2013: In an interim analysis, simeprevir and sofosbuvir showed high cure rates in those who had failed a hep C therapy and had mild to moderate fibr... Top 10 HIV Treatment and Prevention Advances of the Past Decade Jan 30, 2020: 1 2 3 4 5 6 7 8 Next Advertisement Hot topics Forums: Support and discussion Blogs: The community speaks POZ Stories: Get inspired Magazine: Search the archives HIV: The Basics Recursos de VIH/SIDA en Español AIDS Is Everyday Ask POZ